{"transactions":[{"id":1428115,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-08-20T22:40:42.000Z","date":"2024-08-19","kind":"sale","planned":false,"acquired":false,"shares":31747,"price":15.28,"value":485094.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of performance stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.28 to $15.325, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":186555,"source":{"system":"sec-edgar","filing":"0001415889-24-021724","document":"form4-08202024_100838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924021724/form4-08202024_100838.xml","form_type":"4"}},{"id":1428114,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-08-20T22:40:42.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":44782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on May 1, 2023 at 50% of target."}],"balance_after":218302,"source":{"system":"sec-edgar","filing":"0001415889-24-021724","document":"form4-08202024_100838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924021724/form4-08202024_100838.xml","form_type":"4"}},{"id":1428113,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-08-20T22:40:42.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":17333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on April 5, 2022 at incremental 25% of target. Together with the vesting on March 25, 2024, the performance stock units have vested at 75% of target."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 956 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on May 15, 2024."}],"balance_after":173520,"source":{"system":"sec-edgar","filing":"0001415889-24-021724","document":"form4-08202024_100838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924021724/form4-08202024_100838.xml","form_type":"4"}},{"id":1529058,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-05-03T22:00:28.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":false,"shares":22391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":67173,"derivative":{"underlying":"Common Stock","underlying_shares":22391},"source":{"system":"sec-edgar","filing":"0001415889-24-012238","document":"form4-05032024_060513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924012238/form4-05032024_060513.xml","form_type":"4"}},{"id":1529057,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:28.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":11427,"price":16.94,"value":193573.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.94 to $17.015, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":155231,"source":{"system":"sec-edgar","filing":"0001415889-24-012238","document":"form4-05032024_060513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924012238/form4-05032024_060513.xml","form_type":"4"}},{"id":1529056,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:28.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":22391,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":166658,"source":{"system":"sec-edgar","filing":"0001415889-24-012238","document":"form4-05032024_060513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924012238/form4-05032024_060513.xml","form_type":"4"}},{"id":1544776,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-04-09T22:00:18.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":false,"shares":34666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from April 5, 2022 (the \"grant date\"); 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from April 5, 2022 (the \"grant date\"); 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":138666,"derivative":{"underlying":"Common Stock","underlying_shares":34666},"source":{"system":"sec-edgar","filing":"0001415889-24-010604","document":"form4-04092024_060410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010604/form4-04092024_060410.xml","form_type":"4"}},{"id":1544775,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-04-09T22:00:18.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":false,"shares":17333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":34667,"derivative":{"underlying":"Common Stock","underlying_shares":17333},"source":{"system":"sec-edgar","filing":"0001415889-24-010604","document":"form4-04092024_060410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010604/form4-04092024_060410.xml","form_type":"4"}},{"id":1544774,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-04-09T22:00:18.000Z","date":"2024-04-08","kind":"sale","planned":false,"acquired":false,"shares":17716,"price":17.87,"value":316584.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.77 to $17.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":144267,"source":{"system":"sec-edgar","filing":"0001415889-24-010604","document":"form4-04092024_060410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010604/form4-04092024_060410.xml","form_type":"4"}},{"id":1544773,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-04-09T22:00:18.000Z","date":"2024-04-08","kind":"sale","planned":false,"acquired":false,"shares":8858,"price":17.87,"value":158292.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.775 to $17.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":161983,"source":{"system":"sec-edgar","filing":"0001415889-24-010604","document":"form4-04092024_060410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010604/form4-04092024_060410.xml","form_type":"4"}},{"id":1544772,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-04-09T22:00:18.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":true,"shares":34666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":170841,"source":{"system":"sec-edgar","filing":"0001415889-24-010604","document":"form4-04092024_060410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010604/form4-04092024_060410.xml","form_type":"4"}},{"id":1544771,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-04-09T22:00:18.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":true,"shares":17333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":136175,"source":{"system":"sec-edgar","filing":"0001415889-24-010604","document":"form4-04092024_060410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010604/form4-04092024_060410.xml","form_type":"4"}},{"id":1559836,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-27T23:58:15.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":286451,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 25, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":286451,"derivative":{"exercise_price":17.84,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":286451},"source":{"system":"sec-edgar","filing":"0001415889-24-009271","document":"form4-03272024_110307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009271/form4-03272024_110307.xml","form_type":"4"}},{"id":1559835,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-27T23:58:15.000Z","date":"2024-03-27","kind":"sale","planned":false,"acquired":false,"shares":17714,"price":17.9,"value":317080.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of performance stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":118842,"source":{"system":"sec-edgar","filing":"0001415889-24-009271","document":"form4-03272024_110307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009271/form4-03272024_110307.xml","form_type":"4"}},{"id":1559834,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-27T23:58:15.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":34666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on April 5, 2022 at 50% of target."}],"balance_after":136556,"source":{"system":"sec-edgar","filing":"0001415889-24-009271","document":"form4-03272024_110307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009271/form4-03272024_110307.xml","form_type":"4"}},{"id":1616808,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-02-27T23:02:20.000Z","date":"2024-02-23","kind":"exercise","planned":false,"acquired":false,"shares":10946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."}],"balance_after":10946,"derivative":{"underlying":"Common Stock","underlying_shares":10946},"source":{"system":"sec-edgar","filing":"0001415889-24-005572","document":"form4-02272024_110210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924005572/form4-02272024_110210.xml","form_type":"4"}},{"id":1616807,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-02-27T23:02:20.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":5577,"price":24.67,"value":137584.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":101890,"source":{"system":"sec-edgar","filing":"0001415889-24-005572","document":"form4-02272024_110210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924005572/form4-02272024_110210.xml","form_type":"4"}},{"id":1616806,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-02-27T23:02:20.000Z","date":"2024-02-23","kind":"exercise","planned":false,"acquired":true,"shares":10946,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":107467,"source":{"system":"sec-edgar","filing":"0001415889-24-005572","document":"form4-02272024_110210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924005572/form4-02272024_110210.xml","form_type":"4"}},{"id":1683135,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2024-01-09T23:00:35.000Z","date":"2024-01-06","kind":"exercise","planned":false,"acquired":false,"shares":9528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9528},"source":{"system":"sec-edgar","filing":"0001209191-24-001269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919124001269/doc4.xml","form_type":"4"}},{"id":1683134,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-01-09T23:00:35.000Z","date":"2024-01-08","kind":"sale","planned":false,"acquired":false,"shares":3732,"price":29.96,"value":111810.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.63 to $29.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":96521,"source":{"system":"sec-edgar","filing":"0001209191-24-001269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919124001269/doc4.xml","form_type":"4"}},{"id":1683133,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-01-09T23:00:35.000Z","date":"2024-01-06","kind":"exercise","planned":false,"acquired":true,"shares":9528,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,594 shares acquired by the Reporting Person under the Issuer's 2004 Employee Stock Purchase Plan on May 15, 2023.  On October 6, 2023, the Reporting Person filed a Form 4 which reported the same acquisition of shares in a footnote to Table I, Column 5, but inadvertently omitted such shares from the total in Table I, Column 5.  The May 15, 2023 acquisition by the Reporting Person under the Issuer's 2004 Employee Stock Purchase Plan is now correctly included in Table I, Column 5 of this Form 4."}],"balance_after":100253,"source":{"system":"sec-edgar","filing":"0001209191-24-001269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919124001269/doc4.xml","form_type":"4"}},{"id":1763902,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-10-07T01:59:10.000Z","date":"2023-10-06","kind":"exercise","planned":false,"acquired":false,"shares":103999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":173332,"derivative":{"underlying":"Common Stock","underlying_shares":103999},"source":{"system":"sec-edgar","filing":"0001209191-23-052389","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123052389/doc4.xml","form_type":"4"}},{"id":1763901,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-10-07T01:59:10.000Z","date":"2023-10-06","kind":"sale","planned":false,"acquired":false,"shares":51563,"price":21.96,"value":1132323.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":89131,"source":{"system":"sec-edgar","filing":"0001209191-23-052389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123052389/doc4.xml","form_type":"4"}},{"id":1763900,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-10-07T01:59:10.000Z","date":"2023-10-05","kind":"exercise","planned":false,"acquired":true,"shares":103999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,594 shares acquired by the Reporting Person under the Issuer's 2004 Employee Stock Purchase Plan on May 15, 2023."}],"balance_after":140694,"source":{"system":"sec-edgar","filing":"0001209191-23-052389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123052389/doc4.xml","form_type":"4"}},{"id":1828107,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-18T22:00:06.000Z","date":"2023-07-14","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option vest and become exercisable on July 15, 2015. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":220000,"derivative":{"exercise_price":20.77,"expiration_date":"2024-07-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-042641","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123042641/doc4.xml","form_type":"4"}},{"id":1828106,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-07-18T22:00:06.000Z","date":"2023-07-14","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":30.0435,"value":3004350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":36695,"source":{"system":"sec-edgar","filing":"0001209191-23-042641","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123042641/doc4.xml","form_type":"4"}},{"id":1828105,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-07-18T22:00:06.000Z","date":"2023-07-14","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":20.77,"value":2077000.0,"ownership":{"direct":true},"balance_after":136695,"source":{"system":"sec-edgar","filing":"0001209191-23-042641","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123042641/doc4.xml","form_type":"4"}},{"id":1830514,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-07-14T00:27:47.000Z","date":"2023-07-12","kind":"sale","planned":true,"acquired":false,"shares":55104,"price":25.0517,"value":1380448.8768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":36695,"source":{"system":"sec-edgar","filing":"0001209191-23-042246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123042246/doc4.xml","form_type":"4"}},{"id":1830513,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-07-14T00:27:47.000Z","date":"2023-07-11","kind":"sale","planned":true,"acquired":false,"shares":16498,"price":25,"value":412450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."}],"balance_after":91799,"source":{"system":"sec-edgar","filing":"0001209191-23-042246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123042246/doc4.xml","form_type":"4"}},{"id":1906755,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-05-04T01:16:30.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":89564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":89564,"derivative":{"underlying":"Common Stock","underlying_shares":89564},"source":{"system":"sec-edgar","filing":"0001209191-23-027206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123027206/doc4.xml","form_type":"4"}},{"id":1906754,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-04T01:16:30.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":295503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on May 1, 2024. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":295503,"derivative":{"exercise_price":21.75,"expiration_date":"2033-05-01","underlying":"Common Stock","underlying_shares":295503},"source":{"system":"sec-edgar","filing":"0001209191-23-027206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123027206/doc4.xml","form_type":"4"}},{"id":1909002,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-05-02T23:02:53.000Z","date":"2023-04-29","kind":"exercise","planned":false,"acquired":false,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001209191-23-026742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123026742/doc4.xml","form_type":"4"}},{"id":1909001,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-02T23:02:53.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":7806,"price":21.18,"value":165331.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":108297,"source":{"system":"sec-edgar","filing":"0001209191-23-026742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123026742/doc4.xml","form_type":"4"}},{"id":1909000,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-02T23:02:53.000Z","date":"2023-04-29","kind":"exercise","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":116103,"source":{"system":"sec-edgar","filing":"0001209191-23-026742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123026742/doc4.xml","form_type":"4"}},{"id":1923190,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-04-08T00:34:55.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":false,"shares":17333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":52000,"derivative":{"underlying":"Common Stock","underlying_shares":17333},"source":{"system":"sec-edgar","filing":"0001209191-23-023862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023862/doc4.xml","form_type":"4"}},{"id":1923189,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-04-08T00:34:55.000Z","date":"2023-04-06","kind":"sale","planned":false,"acquired":false,"shares":8582,"price":18.16,"value":155849.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.16 to $18.1752, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":100478,"source":{"system":"sec-edgar","filing":"0001209191-23-023862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023862/doc4.xml","form_type":"4"}},{"id":1923188,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-04-08T00:34:55.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":true,"shares":17333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":109060,"source":{"system":"sec-edgar","filing":"0001209191-23-023862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023862/doc4.xml","form_type":"4"}},{"id":1991072,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-02-28T02:00:28.000Z","date":"2023-02-23","kind":"exercise","acquired":false,"shares":10945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."}],"balance_after":21892,"derivative":{"underlying":"Common Stock","underlying_shares":10945},"source":{"system":"sec-edgar","filing":"0001209191-23-013472","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013472/doc4.xml","form_type":"4"}},{"id":1991071,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-02-28T02:00:28.000Z","date":"2023-02-24","kind":"sale","acquired":false,"shares":3851,"price":18.78,"value":72321.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":91727,"source":{"system":"sec-edgar","filing":"0001209191-23-013472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013472/doc4.xml","form_type":"4"}},{"id":1991070,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-02-28T02:00:28.000Z","date":"2023-02-23","kind":"exercise","acquired":true,"shares":10945,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":95578,"source":{"system":"sec-edgar","filing":"0001209191-23-013472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013472/doc4.xml","form_type":"4"}},{"id":2057918,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2023-01-11T01:38:07.000Z","date":"2023-01-06","kind":"exercise","acquired":false,"shares":9528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":9528,"derivative":{"underlying":"Common Stock","underlying_shares":9528},"source":{"system":"sec-edgar","filing":"0001209191-23-002900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123002900/doc4.xml","form_type":"4"}},{"id":2057917,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-01-11T01:38:07.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":3904,"price":17.1303,"value":66876.6912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.13 to $17.1939, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":84633,"source":{"system":"sec-edgar","filing":"0001209191-23-002900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123002900/doc4.xml","form_type":"4"}},{"id":2057916,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-01-11T01:38:07.000Z","date":"2023-01-06","kind":"exercise","acquired":true,"shares":9528,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":88537,"source":{"system":"sec-edgar","filing":"0001209191-23-002900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123002900/doc4.xml","form_type":"4"}},{"id":2063299,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T13:12:31.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":74739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of BLCM common stock. The RSUs vest in full on January 3, 2024, the one-year anniversary of the grant date."}],"balance_after":136854,"source":{"system":"sec-edgar","filing":"0001628280-23-000421","document":"wf-form4_167294233628004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131146/000162828023000421/wf-form4_167294233628004.xml","form_type":"4"}},{"id":2080343,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-20T22:19:23.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":77160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":77160,"derivative":{"exercise_price":2.74,"expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":77160},"source":{"system":"sec-edgar","filing":"0001209191-22-062184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122062184/doc4.xml","form_type":"4"}},{"id":2080342,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T22:19:23.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":38580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on December 16, 2023."}],"balance_after":52032,"source":{"system":"sec-edgar","filing":"0001209191-22-062184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122062184/doc4.xml","form_type":"4"}},{"id":2135802,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2022-10-19T01:16:18.000Z","date":"2022-10-15","kind":"exercise","acquired":false,"shares":5938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5938},"source":{"system":"sec-edgar","filing":"0001209191-22-054026","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122054026/doc4.xml","form_type":"4"}},{"id":2135801,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-10-19T01:16:18.000Z","date":"2022-10-15","kind":"sale","acquired":false,"shares":2804,"price":15.81,"value":44331.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":79009,"source":{"system":"sec-edgar","filing":"0001209191-22-054026","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122054026/doc4.xml","form_type":"4"}},{"id":2135800,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-10-19T01:16:18.000Z","date":"2022-10-15","kind":"exercise","acquired":true,"shares":5938,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":81813,"source":{"system":"sec-edgar","filing":"0001209191-22-054026","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122054026/doc4.xml","form_type":"4"}},{"id":2167920,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-02T10:30:17.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":43400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of BLCM common stock. The RSUs vest in full on September 1, 2023, the one-year anniversary of the grant date."}],"balance_after":62115,"source":{"system":"sec-edgar","filing":"0001628280-22-024220","document":"wf-form4_166212900271886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131146/000162828022024220/wf-form4_166212900271886.xml","form_type":"4"}},{"id":2230347,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T14:49:04.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in full on the one-year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":1.11,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001628280-22-017341","document":"wf-form4_165540533246982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131146/000162828022017341/wf-form4_165540533246982.xml","form_type":"4"}},{"id":2285116,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2022-05-04T00:58:35.000Z","date":"2022-04-29","kind":"exercise","acquired":false,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."}],"balance_after":15625,"derivative":{"underlying":"Common Stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001209191-22-026941","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122026941/doc4.xml","form_type":"4"}},{"id":2285115,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-05-04T00:58:35.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":5483,"price":18.1819,"value":99691.3577,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $18.4025, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":75875,"source":{"system":"sec-edgar","filing":"0001209191-22-026941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122026941/doc4.xml","form_type":"4"}},{"id":2285114,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-05-04T00:58:35.000Z","date":"2022-04-29","kind":"exercise","acquired":true,"shares":15625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":81358,"source":{"system":"sec-edgar","filing":"0001209191-22-026941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122026941/doc4.xml","form_type":"4"}},{"id":2301753,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2022-04-07T22:39:17.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":277331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":277331,"derivative":{"underlying":"Common Stock","underlying_shares":277331},"source":{"system":"sec-edgar","filing":"0001209191-22-023737","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023737/doc4.xml","form_type":"4"}},{"id":2301752,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2022-04-07T22:39:17.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":69333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":69333,"derivative":{"underlying":"Common Stock","underlying_shares":69333},"source":{"system":"sec-edgar","filing":"0001209191-22-023737","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023737/doc4.xml","form_type":"4"}},{"id":2301751,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-07T22:39:17.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":237931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on April 5, 2023. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":237931,"derivative":{"exercise_price":25.75,"expiration_date":"2032-04-05","underlying":"Common Stock","underlying_shares":237931},"source":{"system":"sec-edgar","filing":"0001209191-22-023737","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023737/doc4.xml","form_type":"4"}},{"id":2372877,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2022-02-25T22:40:50.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":10945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."}],"balance_after":32837,"derivative":{"underlying":"Common Stock","underlying_shares":10945},"source":{"system":"sec-edgar","filing":"0001209191-22-013273","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013273/doc4.xml","form_type":"4"}},{"id":2372876,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-02-25T22:40:50.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":3928,"price":23.8,"value":93486.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":65733,"source":{"system":"sec-edgar","filing":"0001209191-22-013273","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013273/doc4.xml","form_type":"4"}},{"id":2372875,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-02-25T22:40:50.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":10945,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":69661,"source":{"system":"sec-edgar","filing":"0001209191-22-013273","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013273/doc4.xml","form_type":"4"}},{"id":2439231,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2022-01-10T23:22:58.000Z","date":"2022-01-06","kind":"exercise","acquired":false,"shares":9527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":19056,"derivative":{"underlying":"Common Stock","underlying_shares":9527},"source":{"system":"sec-edgar","filing":"0001209191-22-002748","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122002748/doc4.xml","form_type":"4"}},{"id":2439230,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-01-10T23:22:58.000Z","date":"2022-01-06","kind":"sale","acquired":false,"shares":3718,"price":23.05,"value":85699.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":58716,"source":{"system":"sec-edgar","filing":"0001209191-22-002748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122002748/doc4.xml","form_type":"4"}},{"id":2439229,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-01-10T23:22:58.000Z","date":"2022-01-06","kind":"exercise","acquired":true,"shares":9527,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1 share of the Issuer's common stock acquired by the reporting person on November 15, 2021 pursuant to an employee stock purchase program."}],"balance_after":62434,"source":{"system":"sec-edgar","filing":"0001209191-22-002748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122002748/doc4.xml","form_type":"4"}},{"id":2441904,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-06T09:31:41.000Z","date":"2022-01-04","kind":"exercise","acquired":false,"shares":18715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full upon the one year anniversary of grant date on January 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full upon the one year anniversary of grant date on January 4, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18715},"source":{"system":"sec-edgar","filing":"0001628280-22-000409","document":"wf-form4_164147948805268.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131146/000162828022000409/wf-form4_164147948805268.xml","form_type":"4"}},{"id":2441903,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T09:31:41.000Z","date":"2022-01-04","kind":"exercise","acquired":true,"shares":18715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer common stock."}],"balance_after":18715,"source":{"system":"sec-edgar","filing":"0001628280-22-000409","document":"wf-form4_164147948805268.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131146/000162828022000409/wf-form4_164147948805268.xml","form_type":"4"}},{"id":2460241,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-23T23:55:30.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":20903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":20903,"derivative":{"exercise_price":9.81,"expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":20903},"source":{"system":"sec-edgar","filing":"0001209191-21-071167","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121071167/doc4.xml","form_type":"4"}},{"id":2460240,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T23:55:30.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":10452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in full on December 22, 2022."}],"balance_after":13452,"source":{"system":"sec-edgar","filing":"0001209191-21-071167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121071167/doc4.xml","form_type":"4"}},{"id":2539770,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2021-10-19T21:30:22.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":5938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."}],"balance_after":5938,"derivative":{"underlying":"Common Stock","underlying_shares":5938},"source":{"system":"sec-edgar","filing":"0001209191-21-060957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121060957/doc4.xml","form_type":"4"}},{"id":2539769,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-10-19T21:30:22.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":2963,"price":17.41,"value":51585.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":52906,"source":{"system":"sec-edgar","filing":"0001209191-21-060957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121060957/doc4.xml","form_type":"4"}},{"id":2539768,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-10-19T21:30:22.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":5938,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 619 shares of the Issuer's common stock acquired by the reporting person on May 14, 2021 pursuant to an employee stock purchase program."}],"balance_after":55869,"source":{"system":"sec-edgar","filing":"0001209191-21-060957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121060957/doc4.xml","form_type":"4"}},{"id":2639834,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-07T20:25:40.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6500,"derivative":{"exercise_price":3.05,"exercise_date":"2022-06-15","expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-21-045942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131146/000120919121045942/doc4.xml","form_type":"4"}},{"id":2734865,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2021-04-30T22:52:19.000Z","date":"2021-04-29","kind":"exercise","acquired":false,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."}],"balance_after":31250,"derivative":{"underlying":"Common Stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001209191-21-029356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121029356/doc4.xml","form_type":"4"}},{"id":2734864,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-30T22:52:19.000Z","date":"2021-04-30","kind":"sale","acquired":false,"shares":7850,"price":20.33,"value":159590.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":49312,"source":{"system":"sec-edgar","filing":"0001209191-21-029356","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121029356/doc4.xml","form_type":"4"}},{"id":2734863,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-04-30T22:52:19.000Z","date":"2021-04-29","kind":"exercise","acquired":true,"shares":15625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities beneficially owned reported in Column 5 above has been adjusted to correct an error in the Reporting Person's prior Form 4 caused by the failure to carry over the correct number of shares from the prior report.  The number of shares owned prior to the transactions reported herein was 41,537 shares."}],"balance_after":57162,"source":{"system":"sec-edgar","filing":"0001209191-21-029356","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121029356/doc4.xml","form_type":"4"}},{"id":2833462,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2021-02-26T02:45:28.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":43782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."}],"balance_after":43782,"derivative":{"underlying":"Common Stock","underlying_shares":43782},"source":{"system":"sec-edgar","filing":"0001209191-21-014557","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121014557/doc4.xml","form_type":"4"}},{"id":2833461,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-26T02:45:28.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":161230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 23, 2022. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":161230,"derivative":{"exercise_price":49.74,"expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":161230},"source":{"system":"sec-edgar","filing":"0001209191-21-014557","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121014557/doc4.xml","form_type":"4"}},{"id":2875060,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-02-09T02:00:26.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":23750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On October 15, 2018, the reporting person was granted an option to purchase shares of common stock based upon and subject to the achievement of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in vesting of the option as to 23,750 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On October 15, 2018, the reporting person was granted an option to purchase shares of common stock based upon and subject to the achievement of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in vesting of the option as to 23,750 shares."}],"balance_after":23750,"derivative":{"exercise_price":21.28,"expiration_date":"2018-10-15","underlying":"Common Stock","underlying_shares":23750},"source":{"system":"sec-edgar","filing":"0001209191-21-008659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121008659/doc4.xml","form_type":"4"}},{"id":2875059,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-02-09T02:00:26.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":40625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On September 7, 2017, the reporting person was granted an option to purchase shares of common stock based upon and subject to the achievement of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in vesting of the option as to 40,625 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 7, 2017, the reporting person was granted an option to purchase shares of common stock based upon and subject to the achievement of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in vesting of the option as to 40,625 shares."}],"balance_after":40625,"derivative":{"exercise_price":35.8,"expiration_date":"2027-09-07","underlying":"Common Stock","underlying_shares":40625},"source":{"system":"sec-edgar","filing":"0001209191-21-008659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121008659/doc4.xml","form_type":"4"}},{"id":2875058,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-02-09T02:00:26.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":40625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On August 3, 2017, the reporting person was granted an option to purchase shares of common stock based upon and subject to the achievement of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in the vesting of the option as to 40,625 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 3, 2017, the reporting person was granted an option to purchase shares of common stock based upon and subject to the achievement of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in the vesting of the option as to 40,625 shares."}],"balance_after":40625,"derivative":{"exercise_price":29.59,"expiration_date":"2027-08-03","underlying":"Common Stock","underlying_shares":40625},"source":{"system":"sec-edgar","filing":"0001209191-21-008659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121008659/doc4.xml","form_type":"4"}},{"id":2875057,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-02-09T02:00:26.000Z","date":"2021-02-04","kind":"sale","acquired":false,"shares":14195,"price":50.61,"value":718408.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":28900,"source":{"system":"sec-edgar","filing":"0001209191-21-008659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121008659/doc4.xml","form_type":"4"}},{"id":2875056,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-02-09T02:00:26.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2019, the Issuer's Compensation Committee determined that the reporting person was granted Restricted Stock Units (RSU's) that vest upon the Issuer's satisfaction of certain performance criteria. On February 4, 2021, certain performance criteria was achieved, resulting in the vesting of the RSU's as to the number of shares reported in column 4 of row 1 above."}],"balance_after":43059,"source":{"system":"sec-edgar","filing":"0001209191-21-008659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121008659/doc4.xml","form_type":"4"}},{"id":2912663,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2021-01-09T00:28:04.000Z","date":"2021-01-06","kind":"exercise","acquired":false,"shares":9527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":28583,"derivative":{"underlying":"Common Stock","underlying_shares":9527},"source":{"system":"sec-edgar","filing":"0001209191-21-002830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002830/doc4.xml","form_type":"4"}},{"id":2912662,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-01-09T00:28:04.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":3484,"price":53.34,"value":185836.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":24482,"source":{"system":"sec-edgar","filing":"0001209191-21-002830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002830/doc4.xml","form_type":"4"}},{"id":2912661,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-01-09T00:28:04.000Z","date":"2021-01-06","kind":"exercise","acquired":true,"shares":9527,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,653 shares of the Issuer's common stock acquired by the reporting person on November 13, 2020 pursuant to an employee stock purchase program."}],"balance_after":27966,"source":{"system":"sec-edgar","filing":"0001209191-21-002830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002830/doc4.xml","form_type":"4"}},{"id":2921744,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-01-05T18:35:52.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":18715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU\") represents a contingent right to receive one share of BLCM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full upon the one year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full upon the one year anniversary of the date of grant."}],"balance_after":18715,"derivative":{"underlying":"Common Stock","underlying_shares":18715},"source":{"system":"sec-edgar","filing":"0001628280-21-000094","document":"wf-form4_160988973836917.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131146/000162828021000094/wf-form4_160988973836917.xml","form_type":"4"}},{"id":2933798,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-23T21:20:07.000Z","date":"2020-12-21","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":18000,"derivative":{"exercise_price":19.46,"expiration_date":"2030-12-21","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-20-065009","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120065009/doc4.xml","form_type":"4"}},{"id":2933797,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-23T21:20:07.000Z","date":"2020-12-21","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were granted as restricted stock units which vest in four equal quarterly installments beginning three months after the date of grant."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-20-065009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120065009/doc4.xml","form_type":"4"}},{"id":3004401,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2020-10-19T21:25:38.000Z","date":"2020-10-15","kind":"exercise","acquired":false,"shares":5937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."}],"balance_after":11876,"derivative":{"underlying":"Common Stock","underlying_shares":5937},"source":{"system":"sec-edgar","filing":"0001209191-20-055315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120055315/doc4.xml","form_type":"4"}},{"id":3004400,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-10-19T21:25:38.000Z","date":"2020-10-16","kind":"sale","acquired":false,"shares":2960,"price":42.56,"value":125977.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":14786,"source":{"system":"sec-edgar","filing":"0001209191-20-055315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120055315/doc4.xml","form_type":"4"}},{"id":3004399,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-10-19T21:25:38.000Z","date":"2020-10-15","kind":"exercise","acquired":true,"shares":5937,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":17746,"source":{"system":"sec-edgar","filing":"0001209191-20-055315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120055315/doc4.xml","form_type":"4"}},{"id":3006587,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-15T20:20:17.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in two equal monthly installments beginning one month after the date of grant."}],"balance_after":765,"derivative":{"exercise_price":15.72,"expiration_date":"2030-10-13","underlying":"Common Stock","underlying_shares":765},"source":{"system":"sec-edgar","filing":"0001209191-20-054905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120054905/doc4.xml","form_type":"4"}},{"id":3109383,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-16T16:51:47.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in full on the one-year anniversary of the grant date."}],"balance_after":6500,"derivative":{"exercise_price":8.42,"expiration_date":"2030-06-14","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001628280-20-009550","document":"wf-form4_159234068895311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131146/000162828020009550/wf-form4_159234068895311.xml","form_type":"4"}},{"id":3147711,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-15T23:11:59.000Z","date":"2020-05-14","kind":"exercise","acquired":false,"shares":88542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The stock option is fully vested and exercisable."}],"balance_after":100000,"derivative":{"exercise_price":19.65,"expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":88542},"source":{"system":"sec-edgar","filing":"0001209191-20-029858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120029858/doc4.xml","form_type":"4"}},{"id":3147710,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-15T23:11:59.000Z","date":"2020-05-13","kind":"exercise","acquired":false,"shares":111458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The stock option is fully vested and exercisable."}],"balance_after":188542,"derivative":{"exercise_price":19.65,"expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":111458},"source":{"system":"sec-edgar","filing":"0001209191-20-029858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120029858/doc4.xml","form_type":"4"}},{"id":3147709,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-05-15T23:11:59.000Z","date":"2020-05-14","kind":"sale","acquired":false,"shares":4321,"price":45.0148,"value":194508.9508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.04, inclusive."}],"balance_after":11809,"source":{"system":"sec-edgar","filing":"0001209191-20-029858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120029858/doc4.xml","form_type":"4"}},{"id":3147708,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-05-15T23:11:59.000Z","date":"2020-05-14","kind":"sale","acquired":false,"shares":84221,"price":45.6489,"value":3844596.0069,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.05 to $46.04, inclusive."}],"balance_after":16130,"source":{"system":"sec-edgar","filing":"0001209191-20-029858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120029858/doc4.xml","form_type":"4"}},{"id":3147707,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-05-15T23:11:59.000Z","date":"2020-05-14","kind":"exercise","acquired":true,"shares":88542,"price":19.65,"value":1739850.3,"ownership":{"direct":true},"balance_after":100351,"source":{"system":"sec-edgar","filing":"0001209191-20-029858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120029858/doc4.xml","form_type":"4"}},{"id":3147706,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-05-15T23:11:59.000Z","date":"2020-05-13","kind":"sale","acquired":false,"shares":8197,"price":45.1173,"value":369826.5081,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.04 to $45.15, inclusive."}],"balance_after":11809,"source":{"system":"sec-edgar","filing":"0001209191-20-029858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120029858/doc4.xml","form_type":"4"}},{"id":3147705,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-05-15T23:11:59.000Z","date":"2020-05-13","kind":"sale","acquired":false,"shares":63392,"price":45.7133,"value":2897857.5136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.16 to $46.15, inclusive."}],"balance_after":20006,"source":{"system":"sec-edgar","filing":"0001209191-20-029858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120029858/doc4.xml","form_type":"4"}},{"id":3147704,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":88198,"kind":"person","name":"DAVIS STEPHEN","position":1,"cik":"0001131146","reported_name":"DAVIS STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-05-15T23:11:59.000Z","date":"2020-05-13","kind":"sale","acquired":false,"shares":20756,"price":46.4302,"value":963705.2312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.16 to $47.15, inclusive."}],"balance_after":83398,"source":{"system":"sec-edgar","filing":"0001209191-20-029858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120029858/doc4.xml","form_type":"4"}}],"next_cursor":"2020-05-15T23:11:59.000000Z,3147704"}